Literature DB >> 16434580

A randomized controlled trial of financial incentives for smoking cessation.

Kevin G Volpp1, Andrea Gurmankin Levy, David A Asch, Jesse A Berlin, John J Murphy, Angela Gomez, Harold Sox, Jingsan Zhu, Caryn Lerman.   

Abstract

BACKGROUND: Although 435,000 Americans die each year of tobacco-related illness, only approximately 3% of smokers quit each year. Financial incentives have been shown to be effective in modifying behavior within highly structured settings, such as drug treatment programs, but this has not been shown in treating chronic disease in less structured settings. The objective of this study was to determine whether modest financial incentives increase the rate of smoking cessation program enrollment, completion, and quit rates in a outpatient clinical setting.
METHODS: 179 smokers at the Philadelphia Veterans Affairs Medical Center who reported smoking at least 10 cigarettes per day were randomized into incentive and non-incentive groups. Both groups were offered a free five-class smoking cessation program at the Philadelphia Veterans Affairs Medical Center. The incentive group was also offered $20 for each class attended and $100 if they quit smoking 30 days post program completion. Self-reported smoking cessation was confirmed with urine cotinine tests.
RESULTS: The incentive group had higher rates of program enrollment (43.3% versus 20.2%; P<0.001) and completion (25.8% versus 12.2%; P=0.02). Quit rates at 75 days were 16.3% in the incentive group versus 4.6% in the control group (P=0.01). At 6 months, quit rates in the incentive group were not significantly higher (6.5%) than in the control group (4.6%; P>0.20).
CONCLUSION: Modest financial incentives are associated with significantly higher rates of smoking cessation program enrollment and completion and short-term quit rates. Future studies should consider including an incentive for longer-term cessation. (Cancer Epidemiol Biomarkers Prev 2006;15(1):12-8).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434580     DOI: 10.1158/1055-9965.EPI-05-0314

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  62 in total

1.  Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment.

Authors:  Darla E Kendzor; Michael S Businelle; Insiya B Poonawalla; Erica L Cuate; Anshula Kesh; Debra M Rios; Ping Ma; David S Balis
Journal:  Am J Public Health       Date:  2014-11-13       Impact factor: 9.308

2.  Designing a model health care system.

Authors:  Kevin G Volpp
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

3.  The use of linear instrumental variables methods in health services research and health economics: a cautionary note.

Authors:  Joseph V Terza; W David Bradford; Clara E Dismuke
Journal:  Health Serv Res       Date:  2008-06       Impact factor: 3.402

4.  What does it cost to change behavior?

Authors:  Bruce A Christiansen
Journal:  Ann Fam Med       Date:  2012 May-Jun       Impact factor: 5.166

5.  Financial Incentives for Smoking Cessation in Hospitalized Patients: A Randomized Clinical Trial.

Authors:  Joseph A Ladapo; Chi-Hong Tseng; Scott E Sherman
Journal:  Am J Med       Date:  2020-01-23       Impact factor: 4.965

6.  Insurance and prevention: ethical aspects.

Authors:  Mikael Dubois
Journal:  J Prim Prev       Date:  2011-02

Review 7.  Patient health incentives: ethical challenges and frameworks.

Authors:  Eran P Klein
Journal:  Int J Behav Med       Date:  2014-12

8.  Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum.

Authors:  Monica S Webb; Peter A Vanable; Michael P Carey; Donald C Blair
Journal:  J Behav Med       Date:  2007-06-15

Review 9.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

10.  Patient opinions regarding 'pay for performance for patients'.

Authors:  Judith A Long; Marie Helweg-Larsen; Kevin G Volpp
Journal:  J Gen Intern Med       Date:  2008-07-29       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.